Pfizer’s Bold Move in Obesity Treatment Landscape

Pfizer just dropped intriguing phase 2 data on a monthly obesity shot that delivered up to 12.3% weight loss—could this...

06/02/2026

3 views

Pfizer Q4 2025 Earnings Beat Expectations

Pfizer just beat Q4 2025 earnings expectations despite plunging COVID sales, posting solid revenue and profit while sticking to its...

03/02/2026

4 views

Pfizer just released its 2026 guidance, and it's more cautious than many expected. With Covid revenue dropping and big acquisitions...

16/12/2025

4 views

Pfizer’s $7B move to dominate obesity drugs sent its stock soaring. But what makes this deal a game-changer for investors?...

22/09/2025

3 views